KallingsL. O.: Resistence factors: influence on netilmicin activity. Scand. J. Infect. Dis., suppl.23; 54 (1980).
2.
GaleE. F.: The molecular basis of antibiotic action.J. Wiley & Sons, London1972.
3.
LuzzatoL.: Polyribosome depletion and blockage of the ribosome cycle by streptomycine. J. Mol. Biol., 42; 315 (1969).
4.
ScolnickE.: Release factors differing in specificity for terminator codons. Proc. Nat. Acad. Sci., 61; 768 (1968).
5.
CarrizosaJ., KayD.: Penicillin and netilmicin in treatment of experimental enterococcal endocarditis. Antimicrob. Agents Chemother., 13; 505–508 (1978).
6.
FuK. P., NeuH. C.: In vitro synergetic effect of netilmicin, a new aminoglycoside antibiotic. Antimicrob. Agents Chemother., 10; 511–518 (1976).
7.
ChadwickP.: Activity of netilmicin compared with those of gentamicin and tobramycin against enterobacteria and Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 12; 301–307 (1977).
8.
KantorR. J., NordenC. W.: In vitro activity of netilmicin, gentamicin, and amikacin. Antimicrob. Agents Chemother., 11; 126–131 (1977).
9.
DhawanV.: In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob. Agents Chemother., 11; 64–73 (1977).
10.
BravenyI.: Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin and amikacin and their resistance patterns. Drug Res., 30; 491–495 (1980).
